CIK: 0001017645
申告総資産額
$21.5億
| # | ティッカー | 発行体 | 資産子分類 | 比率 | 比率変動 | 持株数変化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | DLO | DLocal Limited | 株式-その他 | 22.97% | +5.20% | — | |
| 2 | CHYM | Chime Financial Inc-cl A | 株式-その他 | 18.63% | -0.10% | +10.68% | |
| 3 | XPEV | Xp INC Class A | 株式-その他 | 12.93% | +5.30% | -11.05% | |
| 4 | ALKT | Alkami Technology INC | 株式-その他 | 9.63% | +1.56% | — | |
| 5 | ALHC | Alignment Healthcare INC | 株式-その他 | 9.05% | -9.05% | EXIT | |
| 6 | RVMD | Revolution Medicines INC | 株式-ヘルスケア | 7.80% | -4.60% | +13.68% | |
| 7 | PHVS | Pharvaris N.V. | 株式-その他 | 7.76% | +2.80% | — | |
| 8 | 260 | Centessa Pharmaceuticals-adr | 株式-その他 | 5.33% | -2.83% | -36.81% | |
| 9 | NRIX | Nurix Therapeutics INC | 株式-その他 | 3.23% | -0.27% | — | |
| 10 | EWCZ | European Wax Center Inc-a | 株式-その他 | 1.64% | +1.89% | — | |
| 11 | RSKD | Riskified Ltd. | 株式-その他 | 0.92% | +0.05% | — | |
| 12 | GROV | Grove Collaborative Holdings | 株式-その他 | 0.09% | +0.06% | — | |
| 13 | ✓ | 株式-その他 | 0.01% | — | -99.29% |
| # | ティッカー | 発行体 | 比率変動 | 持株数変化 | アクション |
|---|---|---|---|---|---|
| 1 | CHYM | Chime Financial Inc-cl A | +7% | +10.68% | 増加 |
| 2 | RVMD | Revolution Medicines INC | +4.3% | +13.68% | 増加 |
| 3 | DLO | DLocal Limited | +3% | — | 変化なし |
| 4 | PHVS | Pharvaris N.V. | +1.7% | — | 変化なし |
| 5 | ALKT | Alkami Technology INC | +0.7% | — | 変化なし |
| 6 | RSKD | Riskified Ltd. | +0.2% | — | 変化なし |
| 7 | EWCZ | European Wax Center Inc-a | +0.1% | — | 変化なし |
| 8 | GROV | Grove Collaborative Holdings | 0% | — | 変化なし |
| 9 | XPEV | Xp INC Class A | -1.5% | -11.05% | 減少 |
| 10 | 260 | Centessa Pharmaceuticals-adr | -1.7% | -36.81% | 減少 |
| 11 | ✓ | -3.2% | -99.29% | 減少 | |
| 12 | ALHC | Alignment Healthcare INC | -3.7% | -45.78% | 減少 |
| 13 | AKRO | Akero Therapeutics INC | — | EXIT | 全売却 |
| 14 | NRIX | Nurix Therapeutics INC | — | NEW | 新規購入 |
| 15 | RPRX | Royalty Pharma plc | — | EXIT | 全売却 |
| 16 | ADAG | Adagene Inc-adr | — | EXIT | 全売却 |
| 17 | ALMS | Alumis INC | — | EXIT | 全売却 |